ABSTRACT

Positron Emission Tomography (PET) ...........................................263 11.4.7 Other Tools ......................................................................................264 11.5 Diagnostics ...................................................................................................264 11.5.1 Cell Labeling Techniques ................................................................265 11.5.2 Nanoinformatics ..............................................................................265 11.5.3 Nanosensors ....................................................................................265 11.5.4 Theranostics ....................................................................................265 11.6 Nanopharmaceuticals ...................................................................................266 11.6.1 Nanocarriers ....................................................................................266 11.6.2 Transdermal Drug Delivery ............................................................266 11.6.3 Lipid Drug Delivery Systems .........................................................267 11.6.4 Caveolae ..........................................................................................267 11.6.5 Protein Based Drug Delivery Systems ............................................267 11.6.6 Nucleic Acid Ligands (Aptamers) ...................................................267 11.6.7 Pulmonary Delivery ........................................................................268 11.6.8 Cell Mediated Drug Delivery ..........................................................268 11.6.9 Microbial Origin For Drug Delivery ...............................................268 11.6.10 Multifunctional Nanodrugs ...........................................................268 11.6.11 Nanoceria ......................................................................................269 11.6.12 Nanoscale Metal Organic Frameworks (NMOF) ..........................269 11.6.13 Anti-cancer Drugs .........................................................................269 11.6.14 Infectious Diseases ........................................................................270